Login Form
Registration
Profile Informations
Login Datas
or login
Details
Mounjaro 15 mg KwikPen is a prescription medicine manufactured by Eli Lilly, containing tirzepatide as its active pharmaceutical ingredient. Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist.
It works by activating GIP and GLP-1 receptors, which are involved in blood glucose regulation, insulin secretion and appetite control.
Mounjaro is indicated for the treatment of insufficiently controlled type 2 diabetes mellitus and weight management in eligible adults, in combination with dietary and lifestyle modifications, according to its approved prescribing information.
The KwikPen is a multi-dose, pre-filled injection device designed to deliver four fixed doses. Each dose contains 15 mg of tirzepatide in 0.6 ml of solution.
Product Features:
-
Brand: Mounjaro
-
Manufacturer: Eli Lilly
-
Active Ingredient: Tirzepatide
-
Strength: 15 mg per dose
-
Total Active Ingredient: 60 mg per pen
-
Concentration: 25 mg/ml
-
Pharmaceutical Form: Solution for injection
-
Administration: Subcutaneous injection
-
Device: Multi-dose pre-filled KwikPen
-
Pack Contents: 1 pre-filled pen containing four doses
-
Total Volume: 2.4 ml
-
Needles: Not included
Mounjaro should only be used according to the instructions of a qualified healthcare professional. Dosage adjustments and treatment decisions must be made by the prescribing clinician.

